Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Alignment Healthcare Inc (NASDAQ: ALHC) closed at $10.92 in the last session, up 0.46% from day before closing price of $10.87. In other words, the price has increased by $0.46 from its previous closing price. On the day, 1.03 million shares were traded. ALHC stock price reached its highest trading level at $11.31 during the session, while it also had its lowest trading level at $10.87.
Ratios:
We take a closer look at ALHC’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 1.78 whereas as Long-Term Debt/Eq ratio is at 1.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on May 30, 2024, Upgraded its rating to Buy and sets its target price to $11 from $7.75 previously.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $10.
Piper Sandler Upgraded its Neutral to Overweight on May 08, 2024, whereas the target price for the stock was revised from $6 to $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 01 ’24 when JOYCE CHRISTOPHER J sold 667 shares for $11.79 per share. The transaction valued at 7,866 led to the insider holds 364,445 shares of the business.
Freeman Robert Thomas sold 21,375 shares of ALHC for $227,824 on Oct 01 ’24. The Chief Financial Officer now owns 243,054 shares after completing the transaction at $10.66 per share. On Oct 02 ’24, another insider, Freeman Robert Thomas, who serves as the Chief Financial Officer of the company, sold 9,125 shares for $11.01 each. As a result, the insider received 100,432 and left with 233,929 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2088995968 and an Enterprise Value of 1946301440. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.94 while its Price-to-Book (P/B) ratio in mrq is 16.88. Its current Enterprise Value per Revenue stands at 0.872 whereas that against EBITDA is -18.617.
Stock Price History:
Over the past 52 weeks, ALHC has reached a high of $12.36, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 12.19%, while the 200-Day Moving Average is calculated to be 44.13%.
Shares Statistics:
According to the various share statistics, ALHC traded on average about 1.22M shares per day over the past 3-months and 2116550 shares per day over the past 10 days. A total of 188.95M shares are outstanding, with a floating share count of 87.23M. Insiders hold about 54.40% of the company’s shares, while institutions hold 41.10% stake in the company. Shares short for ALHC as of 1726185600 were 4752562 with a Short Ratio of 3.90, compared to 1723680000 on 4653862. Therefore, it implies a Short% of Shares Outstanding of 4752562 and a Short% of Float of 3.88.
